Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BERNAQ: Customized Neoadjuvant Chemotherapy by BRCA1 Levels in Breast Cancer
NCT02365805Phase 2Completed
- Sponsor
- Fundación Pública Andaluza para la Gestión de la Investigación
- Start
- Apr 2014
- Primary completion
- Oct 2016
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Cisplatin micelle injection (HA132), docetaxel in breast cancer, sponsored by Fundación Pública Andaluza para la Gestión de la Investigación. Started Apr 2014; status: completed.
02
Drugs
Cisplatin micelle injection (HA132)docetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02365805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02365805.